3 Stocks Boosting The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 3 points (0.0%) at 15,545 as of Thursday, July 25, 2013, 12:49 PM ET. The NYSE advances/declines ratio sits at 1,346 issues advancing vs. 1,602 declining with 83 unchanged.

The Health Services industry currently sits up 0.4% versus the S&P 500, which is unchanged. A company within the industry that increased today was Catamaran ( CTRX), up 1.5%. On the negative front, top decliners within the industry include Intuitive Surgical ( ISRG), down 2.5%, and Baxter International ( BAX), down 1.1%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Grifols ( GRFS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Grifols is up $0.35 (1.1%) to $30.98 on light volume. Thus far, 173,286 shares of Grifols exchanged hands as compared to its average daily volume of 643,000 shares. The stock has ranged in price between $30.28-$31.11 after having opened the day at $30.57 as compared to the previous trading day's close of $30.63.

Grifols, S.A., a specialty biopharmaceutical company, develops, manufactures, and distributes a range of plasma derivative products primarily in the European Union, Spain, the United States, and Canada. Grifols has a market cap of $17.0 billion and is part of the health care sector. Shares are up 17.8% year to date as of the close of trading on Wednesday. Currently there are 2 analysts that rate Grifols a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Grifols as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full Grifols Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Varian Medical Systems ( VAR) is up $1.52 (2.1%) to $73.62 on heavy volume. Thus far, 1.4 million shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 765,000 shares. The stock has ranged in price between $70.80-$73.73 after having opened the day at $71.60 as compared to the previous trading day's close of $72.11.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $7.9 billion and is part of the health care sector. Shares are up 3.2% year to date as of the close of trading on Wednesday. Currently there are 7 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Varian Medical Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Boston Scientific ( BSX) is up $1.11 (11.6%) to $10.72 on heavy volume. Thus far, 45.8 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 18.0 million shares. The stock has ranged in price between $10.40-$11.11 after having opened the day at $10.48 as compared to the previous trading day's close of $9.61.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $13.1 billion and is part of the health care sector. Shares are up 69.3% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null